Imvivabio
1 known investors
Imviva Bio develops allogeneic CAR-T cell therapies for cancer and autoimmune diseases, using its Imviva platform and ANSWER technology with immune-evasion science aimed at improving cell therapy performance and persistence.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Imvivabio do?
- Imviva Bio develops allogeneic CAR-T cell therapies for cancer and autoimmune diseases, using its Imviva platform and ANSWER technology with immune-evasion science aimed at improving cell therapy performance and persistence.
- Who are Imvivabio's investors?
- Imvivabio's investors include 7G BioVentures.